Founded in 1998, ForHealth Technologies specializes in automation technology for intravenous drug preparation and is committed to a mission of advancing patient safety with technology solutions. ForHealth is known for IV automation expertise in hospital pharmacies throughout the U.S., with more than 22+ million patient doses prepared to date.

Offering safety, accuracy, efficiency and reliability, our systems automate the preparation of IV medications, greatly enhancing both the safety of patients and the efficiency of hospital pharmacies. Reducing the level of human intervention and applying automated checks and controls improves safety for patients and clinicians, increases efficiency and supports strategies for cost control.

Financials

Date Type Amount Investors Valuation
11/01/07 Series B 4M New Enterprise Associates, National Healthcare Services, Inc., Red River Ventures, Chisholm Private Capital Partners, LC. Unknown

People

Steve Thomas (CEO, Chairman)

Spence Lloyd (President & COO)

Wahid Khan (Vice President, R&D and Manufacturing)

View more details about all 7 people at ForHealth Technologies

Competitors

VidaCare: One of the greatest challenges facing pre-hospital and hospital emergency medicine is rapidly establishing intravenous (IV)… See Company Profile »
EKR Therapeutics: Headquartered in Bedminster, New Jersey, EKR Therapeutics is a specialty pharmaceutical company focused on the acute-care… See Company Profile »

View more details about this company's competitors

News

Are you getting overcharged by your hospital? Time to become a Smart patient

March 15, 2013 9:13 pm

An article by Steve Brill in Time magazine has provoked debate about whether some patients — specifically the uninsured —… Continue reading ⟩

Life sciences briefing: Monday, Dec. 3, 2007

December 3, 2007 4:33 pm

Featured companies: CoMentis, ForHealth Technologies, Merrimack Pharmaceuticals, QuantomiX, Progenitor Cell Therapy, River Diagnostics, Topaz Pharmaceuticals UPDATED: Expanded items on CoMentis,… Continue reading ⟩

Brownian motion: Personnel moves within the life sciences

June 1, 2007 5:26 pm

Nile Therapeutics, a Berkeley, Calif., biotech hired Peter Strumph, formerly chief of operations for struggling heart-drug maker CV Therapeutics, as… Continue reading ⟩